Corrao Mark

Chief Financial Officer at Apimeds Pharmaceuticals US, Inc. · on record since May 8, 2025
Director at SUCCESS HOLDING GROUP INTERNATIONAL, INC. · on record since Feb 19, 2015
Director at Western Graphite Inc. · on record since Apr 8, 2015
CFO and Secretary at Western Graphite Inc. · on record since Apr 8, 2015
CFO at China Pharmaceuticals Inc · on record since Sep 4, 2015
Chief Financial Officer at NEUROPATHIX, INC. · on record since Aug 7, 2018
CFO & Treasurer at GENEREX BIOTECHNOLOGY CORP · on record since Oct 15, 2018
Chief Financial Officer at BRAIN SCIENTIFIC INC. · on record since Oct 15, 2020
Chief Financial Officer at AmStem Corp · on record since Jan 10, 2022

Insider trading activity of Corrao Mark

Figures computed from official regulatory filings — .

Insufficient history for a statistical track record (fewer than 5 open-market buys).

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Value · USD	Src
NEUROPATHIX, INC.Listing unverified	Mar 16, 2021	AwardD (derivative)	800,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NEUROPATHIX, INC.Listing unverified	May 6, 2020	AwardD (derivative)	800,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Oct 15, 2018	AwardD (derivative)	4,500	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Value · USD	Src
NEUROPATHIX, INC.Listing unverified	Mar 16, 2021	AwardD (derivative)	800,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
NEUROPATHIX, INC.Listing unverified	May 6, 2020	AwardD (derivative)	800,000	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
GENEREX BIOTECHNOLOGY CORPListing unverified	Oct 15, 2018	AwardD (derivative)	4,500	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC